Alexandra Yakusheva: ThrombInnov Debuts at ISTH 2026 with a Focus on Translational Research
Alexandra Yakusheva, Preclinical Scientist at EFS, shared a post on LinkedIn:
“Excited to share something I’ve been working on over the past months.
Together with an amazing team, we have founded ThrombInnov, a CRO dedicated to thrombosis and haemostasis research, with the goal of making advanced preclinical models more accessible to academia and industry.
I’m proud to be one of the co-founders of this project and excited to contribute to building it from the ground up.
Today is also the first day of ISTH 2026, where Pierre Mangin and I will be representing ThrombInnov.
If you’re attending the congress and would like to discuss preclinical thrombosis models, collaborations or simply say hello, we’d be delighted to meet you.”
Stay updated with Hemostasis Today.
-
Oct 19, 2026, 19:44Where You Live Should not Determine Whether You Receive Care – World Federation of Hemophilia
-
Oct 19, 2026, 19:42Belen Bianco: Prevention, Early Suspicion and an Interdisciplinary Approach Save Lives
-
Oct 19, 2026, 19:40Christina Chrysohoou: Catheter-Based LAAC vs OAC for Stroke Prevention in Atrial Fibrillation
-
Oct 19, 2026, 19:38Matthew Flick: A Two-Day Research Meeting on Fibrinogen, Hemostasis and Thrombosis
-
Oct 19, 2026, 19:37Hayat Saeed: Excited to Share Our Publication on the FGL1–Hepcidin Axis in Iron Homeostasis and Disease
-
Oct 19, 2026, 19:08IPAW 2026 Comes to a Close, but the Work Continues – PPTA
-
Oct 19, 2026, 17:44Paul Riley: Moderating a Webinar on Anticoagulation Monitoring
-
Oct 19, 2026, 16:36Christopher Pittman: Blood Clot Prevention Cannot End at Hospital Discharge
-
Oct 19, 2026, 16:13Javier M. Floren: When Immune Cells Move With Their Environment